Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2022 6
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
A single chemotherapy administration induces muscle atrophy, mitochondrial alterations and apoptosis in breast cancer patients.
Mallard J, Hucteau E, Bender L, Moinard-Butot F, Rochelle E, Boutonnet L, Grandperrin A, Schott R, Pflumio C, Trensz P, Kalish-Weindling M, Charles AL, Gény B, Favret F, Pivot X, Hureau TJ, Pagano AF. Mallard J, et al. Among authors: trensz p. J Cachexia Sarcopenia Muscle. 2024 Feb;15(1):292-305. doi: 10.1002/jcsm.13414. Epub 2024 Jan 6. J Cachexia Sarcopenia Muscle. 2024. PMID: 38183352 Free PMC article.
Chemotherapy impairs skeletal muscle mitochondrial homeostasis in early breast cancer patients.
Mallard J, Hucteau E, Charles AL, Bender L, Baeza C, Pélissie M, Trensz P, Pflumio C, Kalish-Weindling M, Gény B, Schott R, Favret F, Pivot X, Hureau TJ, Pagano AF. Mallard J, et al. Among authors: trensz p. J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1896-1907. doi: 10.1002/jcsm.12991. Epub 2022 Apr 4. J Cachexia Sarcopenia Muscle. 2022. PMID: 35373507 Free PMC article.
Development of skeletal muscle atrophy and intermuscular adipose tissue in patients with early breast cancer treated with chemotherapy.
Mallard J, Hucteau E, Bender L, Charlot A, Debrut L, Pflumio C, Trensz P, Schott R, Favret F, Pivot X, Hureau TJ, Pagano AF. Mallard J, et al. Among authors: trensz p. Am J Physiol Cell Physiol. 2022 Oct 1;323(4):C1325-C1332. doi: 10.1152/ajpcell.00373.2022. Epub 2022 Sep 12. Am J Physiol Cell Physiol. 2022. PMID: 36094434 Free PMC article.
Impact of the app-based and nurse-led supportive care program AKO@dom on dose intensity of oral-targeted therapies in patients with metastatic renal cell cancer: a multicentric observational retrospective study.
Gaillard V, Lhuillier A, Bigot C, Pierard L, Trensz P, Burgy M, Schuster C, Malouf G, Fritsch A, Lang H, Tricard T, Borchiellini D, Geoffrois L, Barthelemy P. Gaillard V, et al. Among authors: trensz p. Support Care Cancer. 2022 Aug;30(8):6583-6591. doi: 10.1007/s00520-022-07088-1. Epub 2022 Apr 29. Support Care Cancer. 2022. PMID: 35484315
Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kinase Inhibitor During Endocrine Treatment in Hormone-Sensitive Metastatic Breast Cancer Patients in the Context of the COVID-19 Outbreak.
Martin S, Pflumio C, Trensz P, Schaff-Wendling F, Weindling MK, Fischbach C, Pierard L, Limacher JM, Nader R, Velten M, Petit T. Martin S, et al. Among authors: trensz p. Clin Breast Cancer. 2023 Jan;23(1):32-37. doi: 10.1016/j.clbc.2022.10.006. Epub 2022 Oct 13. Clin Breast Cancer. 2023. PMID: 36414498 Free PMC article.
11 results